title: The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae.
abstract: Antimicrobial resistance is a growing worldwide iatrogenic complication of modern medical care. Extended-spectrum β-lactamases have emerged as one of the most successful resistance mechanisms, limiting our therapeutic options to treat various human infections. The dissemination of these enzymes to the community probably signifies an irreversible step. This paper will review the evolution of human infections associated with extended-spectrum β-lactamase-producing organisms in the past 20 years, and will present and discuss the current challenges, controversies, debates and knowledge gaps in this research field.
authors.affiliation: 1Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
authors.forename: Ruthy
authors.initials: R
authors.lastname: Tal Jasper
authors.forename: Joseph R
authors.initials: JR
authors.lastname: Coyle
authors.affiliation: 3Department of Internal Medicine D, Shaare Zedek Medical Center, Jerusalem, Israel.
authors.forename: David E
authors.initials: DE
authors.lastname: Katz
authors.affiliation: 1Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.|4Division of Infectious Diseases, Assaf Harofeh Medical Center, Zerifin, Israel.
authors.forename: Dror
authors.initials: D
authors.lastname: Marchaim
mesh_terms: D024881:Drug Resistance, Bacterial; D004755:Enterobacteriaceae / Q000201:enzymology* / Q000302:isolation & purification; D004756:Enterobacteriaceae Infections / Q000453:epidemiology* / Q000382:microbiology*; D006801:Humans; D001618:beta-Lactamases / Q000378:metabolism*
chemical_list: D001618:beta-Lactamases
keywords: E. coli; Gram negative; Klebsiella pneumoniae; MDROs; Proteus mirabilis; ST-131; antibiotic stewardship; carbapenem; community acquired; healthcare associated